Navigation Links
New Combination Locking Cap Designed to Protect Children and Teens From Prescription Medications
Date:9/26/2011

LINCOLN, Calif., Sept. 26, 2011 /PRNewswire/ -- Safely storing prescription medications has always been a challenge for parents and other prescription holders. Now, an innovative new device allows prescription holders to safely secure and store dangerous medications—in a small, convenient and more portable container.

(Photo: http://photos.prnewswire.com/prnh/20110926/SF75139)

Developed by CAP-N-LOCK, LLC., The Locking Cap is a combination locking cap designed to work with existing prescription medication bottles. The Locking Cap was designed to help families prevent unauthorized and undetected use of prescription medications for non-medical purposes. With a four-digit combination locking mechanism and sturdy PVC construction, it is easy to use, but virtually impossible to get past without detection.

"The Locking Cap eliminates unauthorized access to dangerous prescription drugs," said Joseph Simpson, President and product designer for CAP-N-LOCK. "The Locking Cap is very easy to operate. It protects families by blocking access to curious children and experimental teens. Plus, it features a compact design that allows for easy access and storage when traveling and at home."

The Locking Cap is designed and manufactured in the United States and is currently available in national pharmacies and online at http://www.TheLockingCap.com

About CAP-N-LOCK, LLC.

CAP-N-LOCK specializes in family safety product design, development, manufacturing and marketing. The non-medical use and abuse of prescription drugs is a serious and growing public health problem in the U.S. and is rapidly becoming a global epidemic. The majority of people use prescription medications responsibly; however, an estimated 48 million people in the U.S. (ages 12 and older) have used prescription drugs for non-medical reasons. The Locking Cap was created to protect families and help prevent prescription drug abuse and overdoses. For more information about The Locking Cap, visit http://www.TheLockingCap.com or call (408) 206-0120.  

Available at Ralphs, SaveMart, and Lucky Pharmacies.

Contact:
Deborah Simpson, Chairman & CEO, CAP-N-LOCK, LLC., at (408) 206-0120 or dsimpson@TheLockingCap.com


'/>"/>
SOURCE CAP-N-LOCK, LLC.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pearl Therapeutics Bronchodilator Combination PT003 Provides Superior Inspiratory Capacity Compared to Spiriva®
2. SANYO Adds New MPR Series Biomedical Refrigerator/Freezer Combination Unit
3. Specialty Silicone Fabricators Adds Analytical Laboratory to Bolster Combination Product Services
4. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
5. Takeda Resubmits New Drug Applications in the U.S. for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
6. Tibotec Pharmaceuticals Announces Agreement With Gilead Sciences to Develop and Commercialize a New Fixed-Dose Combination of PREZISTA® and Cobicistat
7. Launch of Nuromol a New Painkiller Combination
8. ReportsnReports - Multitargeted Therapies: Promiscuous Drugs and Combination Therapies
9. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
10. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
11. All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):